Alnylam Pharmaceuticals in Talks on Cholesterol Drug

Alnylam Pharmaceuticals Inc. is in talks with “more than one” possible partner to help develop the company’s injectable drug to treat high cholesterol in patients for whom statins aren’t effective, Chief Executive Officer John Maraganore said.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.